Growth Metrics

Omeros (OMER) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -27.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.71%
Dec 31, 2025 -16.22%
Sep 30, 2025 11.30%
Jun 30, 2025 -4.09%
Mar 31, 2025 -33.12%
Dec 31, 2024 -16.74%
Sep 30, 2024 -10.65%
Jun 30, 2024 -18.56%
Mar 31, 2024 -1.25%
Dec 31, 2023 -23.68%
Sep 30, 2023 2.24%
Jun 30, 2023 4.90%
Mar 31, 2023 176.30%
Dec 31, 2022 -3.32%
Sep 30, 2022 -52.04%
Jun 30, 2022 -5.48%
Mar 31, 2022 -5.47%
Dec 31, 2021 9.60%
Sep 30, 2021 13.75%
Jun 30, 2021 3.71%
Mar 31, 2021 -52.74%
Dec 31, 2020 -64.01%
Sep 30, 2020 -46.14%
Jun 30, 2020 -66.41%
Mar 31, 2020 10.39%
Dec 31, 2019 -28.43%
Sep 30, 2019 12.47%
Jun 30, 2019 -9.04%
Mar 31, 2019 8.00%
Dec 31, 2018 -14.10%
Sep 30, 2018 -36.22%
Jun 30, 2018 -23.16%
Mar 31, 2018 13.54%
Dec 31, 2017 35.70%
Sep 30, 2017 11.12%
Jun 30, 2017 18.86%
Mar 31, 2017 -4.47%
Dec 31, 2016 -232.32%
Sep 30, 2016 -0.54%
Jun 30, 2016 -10.85%
Mar 31, 2016 -22.85%
Dec 31, 2015 -9.10%
Sep 30, 2015 -25.38%
Jun 30, 2015 -23.14%
Mar 31, 2015 -46.97%
Dec 31, 2014 -28.70%
Sep 30, 2014 -57.16%
Jun 30, 2014 -34.16%
Mar 31, 2014 -12.25%
Dec 31, 2013 -26.92%
Sep 30, 2013 -23.23%